tirzepatide press release A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.⁠ ⁠ The U.S. Food and Drug Administration approved Eli Lilly's Zepbound, or Novo sues Lilly, claiming misleading

The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)

Sitagliptin and glucagon-like peptide-1 (GLP-1) receptor agonists are often confused because both treat type 2 diabetes, but they belong to separate drug classes with distinct mechanisms of action

This is the part you can touch and see

Recurrent weight gain after sleeve gastrectomy: conversion to Roux-en-Y gastric bypass versus novel GLP-1 s

Considerations for Semaglutide Semaglutide, while a valuable medication for body weight management and blood sugar control, is not without safety considerations